ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · IEX Real-Time Price · USD
11.90
+0.66 (5.87%)
At close: Jul 26, 2024, 4:00 PM
12.12
+0.22 (1.85%)
After-hours: Jul 26, 2024, 7:13 PM EDT
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $802.33 million as of July 26, 2024. Its market cap has increased by 129.30% in one year.
Market Cap
802.33M
Enterprise Value
485.55M
1-Year Change
129.30%
Ranking
Category
Stock Price
$11.90
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $709.80M to $802.33M, an increase of 13.04%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 757.80M | 50.99% |
| Dec 29, 2023 | 501.90M | 115.32% |
| Dec 30, 2022 | 233.10M | -59.73% |
| Dec 31, 2021 | 578.90M | -50.50% |
| Dec 31, 2020 | 1.17B | 64.78% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aveanna Healthcare Holdings | 784.91M |
| IGM Biosciences | 780.89M |
| Pliant Therapeutics | 773.38M |
| Phibro Animal Health | 770.78M |
| Stoke Therapeutics | 768.26M |
| Wave Life Sciences | 764.89M |
| Evolus | 764.47M |
| Abivax | 759.41M |